Bavarian Nordic Bags Contract for Advanced Smallpox Vaccine
The federal government will be awarding a $500 million contract to Bavarian Nordic A/S (Kvistgård, Denmark, www.bavarian-nordic.com) to deliver 20 million doses of an advanced smallpox vaccine.
The federal government will be awarding a $500 million contract to Bavarian Nordic A/S (Kvistgård, Denmark, www.bavarian-nordic.com) to deliver 20 million doses of an advanced smallpox vaccine. The government already has a stockpile of vaccine that could be used to immunize every American in the event of a smallpox attack by terrorists. However, as the existing vaccine sometimes causes serious side effects, the Department of Health and Human Services (HHS) is asking the European company to make enough of its vaccine to immunize about 10 million Americans, such as patients on chemotherapy or people with HIV/AIDS. The company said the contract could be worth $1.6 billion.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
